“Marks The Spot“
Healthcare giant builds a heathier future for Asia.
Zuellig Pharma is one of the largest healthcare services groups in Asia. Although incorporated in 2008 in Singapore as the Regional Head Office, they have been operating in Singapore since the 1930s, having started in the Philippines almost a hundred years ago. Their purpose is ‘Making Healthcare More Accessible’ by providing world-class distribution, digital and commercial services to support the growing healthcare needs in this region.
The company has grown to become a US$13 billion business covering 13 markets with over 12,000 employees. Their team serves over 350,000 medical facilities and works with over 1,000 clients, including the top ten pharmaceutical companies in the world. Zuellig Pharma’s sustainability vision is to build a healthier future for Asia with its clients, customers, employees, suppliers and partners. As such the company recognizes that they have tremendous capacity to make a positive impact on the communities they serve in Asia through Sustainability.
Their purpose of ‘Making Healthcare More Accessible’ is ingrained in Zuellig Pharma’s DNA, and sustainability spells out how they are doing so. In the three years since they formalized their Sustainability agenda, the company has marked many sustainable milestones. They have established a solid foundation with the development of a sustainability framework that outlines four key impact pillars, which are improving health outcomes, nurturing talent, respecting the environment and setting the highest standards of integrity.
Zuellig Pharma has also committed to the Ten Principles of the UN Global Compact. They joined the UN Global Compact as a signatory in October 2019, and continuously commit to furthering these principles through submitting an annual Communication on Progress to the UN Global Compact. Their Communication on Progress outlines Zuellig Pharma’s commitments, management systems and activities in the areas of human rights, labour, environment and anti-corruption. In each of these areas, they have identified key performance indicators to measure and report annually. They also publish annual sustainability reports in alignment with prevailing Global Reporting Initiative (GRI) Standards, in support of international efforts for consistent sustainability reporting.
The company strongly believes in integrating sustainability within their business operations, and harnessing their strengths to develop robust sustainability goals. A dedicated team of in-house data analysts have been working on an integrated reporting system this year to help them to tangibly determine their current baseline across their matrix organization on material issues. Once this has been established, they endeavor to set ambitious targets and outline clear plans for achieving them.
Zuellig Pharma championed local and regional movements by joining the United Nations Global Compact, Business for Social Responsibility’s Healthcare Working Group and Green Freight Asia. Their inaugural Sustainability Month in November 2020 saw over 7,000 employees celebrate sustainability in action by participating in future-focused activities around each sustainability pillar.
These were reinforced by World Quality Day and Safety Week initiatives, which united the workforce behind these two important material issues. They also witnessed the active involvement of their suppliers in their first-ever Supplier Sustainability Awards. The company regards their employees to be the heart of Zuellig Pharma, and these activities have led to a growing momentum of immense passion and enthusiasm for sustainability within the organization.
The corporation achieved the EcoVadis Gold Medal 2020 for their sustainability efforts, placing them among the top 1% of companies in their industry as assessed by the sustainability ratings specialist. These milestones have also enabled them to publish their first-ever GRI aligned sustainability report, which details their progress around key material issues.
For Zuellig Pharma, sustainability remains paramount, especially in challenging pandemic times. Integrating sustainability into their business is the new normal, and the healthcare giants are convinced this will help to build a healthier future for Asia for the long haul.
“Zuellig Pharma has demonstrated how huge corporations can spearhead sustainability through the push down effect from top management, resulting in considerable change organizationally, as well as via the ripple effect to its suppliers and consumers.”
Shanggari Balakrishnan, Chief Executive Officer, MORS Group